258 related articles for article (PubMed ID: 30446448)
1. Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer.
Cormie P; Zopf EM
Urol Oncol; 2020 Feb; 38(2):62-70. PubMed ID: 30446448
[TBL] [Abstract][Full Text] [Related]
2. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
[TBL] [Abstract][Full Text] [Related]
3. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
[TBL] [Abstract][Full Text] [Related]
4. Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.
Bressi B; Cagliari M; Contesini M; Mazzini E; Bergamaschi FAM; Moscato A; Bassi MC; Costi S
Support Care Cancer; 2021 Apr; 29(4):1811-1824. PubMed ID: 33119791
[TBL] [Abstract][Full Text] [Related]
5. Improving Physical and Mental Health in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy: Strategies to Promote and Improve Physical Activity Quality and Quantity.
Toohey K; McKune A; Nahon I; Kavanagh PS; Newton RU; Paterson C
Semin Oncol Nurs; 2020 Aug; 36(4):151051. PubMed ID: 32682582
[TBL] [Abstract][Full Text] [Related]
6. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Leslie WD; Lau YK
BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
[TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
9. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
Baguley BJ; Skinner TL; Leveritt MD; Wright OR
BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
[TBL] [Abstract][Full Text] [Related]
10. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
[TBL] [Abstract][Full Text] [Related]
11. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training.
Mundell NL; Daly RM; Macpherson H; Fraser SF
Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634
[TBL] [Abstract][Full Text] [Related]
12. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
[TBL] [Abstract][Full Text] [Related]
13. Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf study.
Reimer N; Hafke R; Wrensch M; Horst P; Bloch W; Hahn T; Kirchhoff A; Kluck KL; Stein J; Baumann FT
Contemp Clin Trials; 2022 Mar; 114():106685. PubMed ID: 35065281
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Kilgour A; Lau YK
BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
[TBL] [Abstract][Full Text] [Related]
16. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
[TBL] [Abstract][Full Text] [Related]
17. The Effect on Bone Outcomes of Home-based Exercise Intervention for Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: A Pilot Randomized Controlled Trial.
Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song Y; Song H
Cancer Nurs; 2018; 41(5):379-388. PubMed ID: 28731882
[TBL] [Abstract][Full Text] [Related]
18. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
Trials; 2014 Sep; 15():354. PubMed ID: 25199619
[TBL] [Abstract][Full Text] [Related]
19. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
Gardner JR; Livingston PM; Fraser SF
J Clin Oncol; 2014 Feb; 32(4):335-46. PubMed ID: 24344218
[TBL] [Abstract][Full Text] [Related]
20. Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial.
Focht BC; Lucas AR; Grainger E; Simpson C; Fairman CM; Thomas-Ahner JM; Buell J; Monk JP; Mortazavi A; Clinton SK
Ann Behav Med; 2018 Apr; 52(5):412-428. PubMed ID: 29684136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
